Abhimanyu Garg
Director of the Nutrition and Metabolic Diseases Fellowship Program · UT Southwestern Medical Center
Credentials: · · ·
History
PresentNutrition and Metabolic Diseases Fellowship · UT Southwestern Medical Center
- Present
Metabolic Diseases in the Center for Human Nutrition · UT Southwestern Medical Center
- 1985–1987
- 1983
ECFMG
Research
Leptin-replacement therapy for lipodystrophy
New England Journal of Medicine · 2002 · Last of 12 authors · 929 citations
Acquired and inherited lipodystrophies
Review · New England Journal of Medicine · 2004 · Sole author · 658 citations
Relationships of generalized and regional adiposity to insulin sensitivity in men
Journal of Clinical Investigation · 1995 · 610 citations
- SG
28 papers
23 papers · 11 as a fellow
18 papers · 5 as a fellow
- EO
14 papers
14 papers · 3 as a fellow
10 papers
- NA
10 papers
- RB
10 papers
Grants
- 2015–2030
Genetic and Metabolic Basis of Familial Lipodystrophies
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $6.5M · Ut Southwestern Medical Center
- 2023–2028
National Heart, Lung, and Blood Institute · R33
Contact PI · $864.3K · Ut Southwestern Medical Center
- 2024–2028
Autoimmune Basis of Acquired Lipodystrophies
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.7M · Ut Southwestern Medical Center
- 2023–2024
National Heart, Lung, and Blood Institute · R61
Contact PI · $550.6K · Ut Southwestern Medical Center
Clinical trials
- 2024–2029
Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
Principal investigator · Recruiting · Phase 2
University of Texas Southwestern Medical Center
- 2016–2022
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Principal investigator · Completed · Phase 2
Abhimanyu Garg
- 2015–2022
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
- 2015–2020
Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Principal investigator · Terminated · Phase 2
University of Texas Southwestern Medical Center